Login
| TI Ref No : | 528542625 |
|---|---|
| Description : | A Sebelipase Alfa (genetical Recombinaion, 20mg 10ml/1vial) 147 Vials, B Nushinersen Sodium (12mg/1vial) 2 Vials, C Cetuximab Sarotalocan Sodium (genetical Recombination, 250mg 50ml/1vial) 62 Vials, D Polatuzumab Vedotin (genetical Recombinat... |
| Date : | 2026-02-06 |
| Deadline : | 2026-04-03 |
| Document Type : | Tenders |
